Context
ICMR is working to develop the first-ever vaccine for shigella.
About Shigella Vaccine:
- There is no approved vaccine against shigella yet
- ICMR-National Institute for Research in Bacterial Infections (NIRBI) has developed a vaccine that has passed animal trials.
About Shigella
- Caused by bacteria that causes shigellosis.
- 2nd leading cause of diarrhoea worldwide (after Rotavirus) and the 3rd leading cause of death in children under five.
- Modes of Transmission: Shigella spreads through contaminated food or water, or person-to-person contact.
- Incubation Period: is usually 1–4 days.
Source: The Print
Previous Year Question
In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements:
1. The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform.
2. Sputnik V vaccine is manufactured using vector-based platform.
3. COVAXIN is an inactivated pathogen-based vaccine.
Which of the statements given above are correct?
[UPSC Civil Services Exam – 2022 Prelims]
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (a)
